Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Daisyu Toya"'
Autor:
Yukihiro Bando, Hitomi Tohyama, Keiko Aoki, Hideo Kanehara, Azusa Hisada, Kazuhiro Okafuji, Daisyu Toya
Publikováno v:
Journal of Clinical & Translational Endocrinology, Vol 6, Iss C, Pp 1-7 (2016)
Aims: This preliminary randomized, parallel-group comparative study evaluated the efficacy of ipragliflozin for reduction of small dense low-density lipoprotein cholesterol (sd LDL-C) levels in Japanese patients with type 2 diabetes mellitus (T2DM).
Externí odkaz:
https://doaj.org/article/031132d3b0d742819c1bb8e226f969dc
Autor:
Teruyuki Ueda, Daisyu Toya, Hiroyuki Watanabe, Kazuo Notsumata, Taku Sanada, Yoshimoto Nomura
Publikováno v:
Kanzo. 61:367-373
Autor:
Hiroyuki Watanabe, Akihiro Tanaka, Taku Sanada, Kazuo Notsumata, Teruyuki Ueda, Daisyu Toya, Yoshimoto Nomura, Yoshikatsu Nomura
Publikováno v:
Internal Medicine
Objective We started an information technology (IT) system that encodes the medical treatment status of hepatitis B virrus (HBV) with a 9-digit number, automatically checks for inappropriate situations occurring due to immunosuppression and chemother
Publikováno v:
Interventional Radiology. 2:10-13
Autor:
Teruyuki Ueda, Daisyu Toya, Taku Sanada, Akihiro Tanaka, Kazuo Notsumata, Yoshimoto Nomura, Masataka Kanno, Hiroyuki Watanabe
Publikováno v:
Kanzo. 58:255-258
Autor:
Daisyu Toya, Hideo Kanehara, Kazuhiro Okafuji, Yukihiro Bando, Azusa Hisada, Keiko Aoki, Hitomi Tohyama
Publikováno v:
Journal of Clinical & Translational Endocrinology, Vol 6, Iss C, Pp 1-7 (2016)
Journal of Clinical & Translational Endocrinology
Journal of Clinical & Translational Endocrinology
Highlights • Small dense LDL-C (sd LDL-C) convey cardiovascular risk in type 2 diabetes (T2D). • Ipragliflozin reduced sd LDL-C levels in Japanese patients with T2D. • Changes in body weight, TG and LDL-C levels contributed to sd LDL-C reductio
Autor:
Takeshi Urabe, Manabu Yonejima, Hiroshi Kawai, Akito Sakai, Tatsuya Yamashita, Yoshinobu Hinoue, Daisyu Toya, Hajime Ohta, Takeshi Terashima, Yatsugi Noda, Eishiro Mizukoshi, Shuichi Kaneko
Publikováno v:
Japanese journal of clinical oncology. 48(11)
Background FOLFIRINOX (FFX) and gemcitabine (GEM) plus nab-paclitaxel (GnP) have recently been available for treating pancreatic ductal adenocarcinoma (PDAC). We investigated trends in characteristics, treatment and outcomes of unselected patients wi
Autor:
Yukihiro Bando, Kazuhiro Okafuji, Daisyu Toya, Keiko Aoki, Nobuyoshi Tanaka, Kousuke Shima, Hideo Kanehara, Azusa Hisada
Publikováno v:
Journal of Diabetes Mellitus. :28-35
Background: Treatment for postprandial glycemia using rapid-acting insulin analogues sometimes resulted in preprandial hypoglycemia or weight gain. Objective: This study evaluated the efficacy and safety of switching bolus insulin from insulin lispro
Autor:
Yukihiro Bando, Kazuhiro Okafuji, Hideo Kanehara, Daisyu Toya, Nobuyoshi Tanaka, Masayuki Yamada, Azusa Hisada, Keiko Aoki
Publikováno v:
Diabetology International. 5:229-233
Aims This study assessed the independent predictors of the hemoglobin A1c (HbA1c)-lowering effect of vildagliptin in Japanese patients with type 2 diabetes.
Autor:
Kazuo Notsumata, Nobuyoshi Tanaka, Hisato Matsuda, Hiroyuki Igarashi, Yuichi Nushimo, Tatsuo Kumai, Masaki Sano, Hiroyuki Watanabe, Taku Sanada, Hirokazu Shin, Teruyuki Ueda, Daisyu Toya
Publikováno v:
Kanzo. 55:91-99